Search

everythinglearnresearchcommunity

for

Search:↓

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.

Low-level light therapy can safely and effectively stimulate hair growth in people with androgenetic alopecia.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

The new method is 1000 times more sensitive for measuring hair growth.

Both PRP and L-GF treatments improved hair transplant results, with L-GF being slightly better, but the difference was not significant.

GFC is more effective than PRP for treating hair loss.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

BST2 protein and certain T cells increase in early alopecia areata.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

The rhg mutation in mice affects the Oat gene, causing hair growth issues and other symptoms.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Sheep hair follicle transglutaminases are calcium-dependent.

LGD1069 effectively prevents breast tumors in mice without toxicity.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Both treatments for alopecia areata are equally effective and safe.

The new topical growth hormone formula has high skin penetration and bioavailability.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

LLLT is a safe, promising hair loss treatment, but more research needed.

LLLT devices for hair loss need more research to define proper guidelines.